Biotech componentsMicrobe

Products 11 to 16 of 16

Rose Oil From Yeast by Ginkgo Bioworks
Biotech components: Microbe + Yeast
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/11/28 16:10 (5 years ago)
Known funding amount: 9,000,000 USD
Funding types: Private Funding
Industry: Novelty
Market status: Under Development
Organization type(s): Private Company
Product categories: Other
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
SYN-004 (RIBAXAMASE) by Synthetic Biologics
Biotech components: Microbe
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/08/30 11:49 (5 years ago)
Known funding amount: 12,467,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: SYN (NYSEMKT)
Value chain stage: Finished Product
SYNB1020 by Synlogic
Biotech components: Microbe
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Consumer + Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/08/30 11:49 (5 years ago)
Known funding amount: 125,800,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: Web search
Trading symbol: SYBX (NASDAQ)
Value chain stage: Finished Product
SYNB1618 by Synlogic
Biotech components: Microbe
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial + Consumer
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/10/08 14:53 (5 years ago)
Known funding amount: 125,800,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: Web search
Trading symbol: SYBX (NASDAQ)
Value chain stage: Finished Product
Biotech components: Microbe + Fungus
Business models: B2B
Country of production: USA
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/08/30 11:49 (5 years ago)
Known funding amount: 179,800,000 USD
Funding types: Venture Capital
Industry: Industrial
Market status: On the market
Organization type(s): Private Company
Product categories: Fuel and Energy + Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Vanillin by Evolva
Biotech components: Microbe + Fungus
Business models: B2B
Country of production: USA
Country of distribution: Switzerland + USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/08/30 11:49 (5 years ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Public Company
Product categories: Additive
Production process: Closed Production
Source: SynBio Database
Trading symbol: EVE (SWX)
Value chain stage: Input